
SynBioBeta 2026 Speaker
Victor Gotho
Enzyva
CEO
Enzyva: Precision Engineering for the Bio-EconomyThe bio-revolution is no longer about discovery; it is about performance and predictability. At Enzyva, we have moved past the experimental phase of synthetic biology to deliver high-impact, scalable solutions for the most demanding industries.The Problem: The Industrial BottleneckMost biological innovations fail when they hit the real world. They are too unstable, too inconsistent, or simply too expensive to scale. The market is tired of "lab-scale" promises that canโt meet industrial-grade KPIs.The Solution: The Enzyva EdgeEnzyva has developed a proprietary platform that optimizes biological systems for maximum output and reliability. We specialize in:Predictive Optimization: Taking the guesswork out of bio-based production.Industrial Robustness: Ensuring our solutions perform under real-world pressures.Operational Speed: Reducing the time between concept and commercialization.Strategic Leadership & ExpertiseMy expertise lies in operational strategy and the commercialization of complex technologies. I focus on the "Bio-Business" bridge. While our technical team pushes the boundaries of what's possible, my role is to ensure those breakthroughs are economically viable, scalable, and ready for market integration. I specialize in navigating the transition from a technical proof-of-concept to a robust, revenue-generating operation.Why Enzyva?We are here at SynBioBeta to connect with partners who demand more than just innovationโthey demand results. We are looking for collaborators ready to integrate Enzyvaโs superior biological performance into their core value chain.Enzyva: Biology at the speed of business.



Reagan
Jarvis
Anocca AB
CEO, Co-founder

Alex
Rives
CZI Biohub
Head of Science

Karenโฏ
Akinsanya
Schrodinger
President, R&D โ Therapeutics

Christopher
Arendt
Takeda
CSO, Head of Research

Stef
van Grieken
Cradle
CEO

Michael
Koeris
DARPA
Director, BTO

Jennifer
Dionne
Pumpkinseed
CEO

Daniyal
Hussain
GSK
Exec. Dir., Tech BD

Cynthia
Hong
Novartis
Dir., Search & Evaluation
SynBioBeta 2027 May 3-6, San Jose, California


